Practical Pediatrics Conference 2026

Event Start/Stop Date and Time

March 27, 2026 8:00 AM - March 28, 2026 12:15 PM EDT

Check-in Date and Time

• Practical Pediatrics Conference 2026 Day 1 Only
  March 27, 2026 7:45 AM EDT
• Practical Pediatrics Conference 2026 Full 2 days
  March 27, 2026 7:45 AM EDT
• Practical Pediatrics Conference 2026 Day 2 only
  March 28, 2026 7:45 AM EDT

Location

Wake Forest University Bridger Field House
499 Deacon Blvd.
Winston Salem, NC, 27105

Event Description

This continuing medical education activity is intended for pediatricians, as well as family medicine physicians, physician assistants, nurse practitioners and nurses who provide care to infants, children and adolescents. Travel Accommodations We have secured a block of discounted hotel rooms at The Brookstown Inn. Book using the information below. The Historic Brookstown Inn Trademark Collection by Wyndham 200 Brookstown Ave Winston-Salem, NC 27101 Phone: 336-701-3904 Email: info@brookstowninn.com Client/Organization Group Name: Wake Forest Pediatrics Conference Group Contact: Stacy Thomas Email: Stacy.Thomas@wufsm.edu Reservation Details Check-in Date: 03/26/2026 Check-out Date: 03/28/2026 Release Date: 02/26/2026 Group Code: 032626WAK For reservations, guests must mention the group name to receive the group rate. Call: 336-701-3904 Email: frontdesk@brookstowninn.com Book Online: https://www.wyndhamhotels.com/trademark/winston-salem-north-carolina/the-historic-brookstown-inn-trademark-collection/rooms-rates?&checkInDate=03/26/2026&checkOutDate=03/28/2026&groupCode=032626WAK Cancellations received at least 14 business days before the activity will receive 100% refund. Registrants cancelling between 2 weeks and 2 full business days prior to the first day of the event will be refunded at 70% and are subject to a minimum $25 cancellation fee. Registration fee will not be refunded if canceled less than 2 days before the activity. Cancellations must be in writing. Registrants may send a substitute in their place to avoid cancellation fees.

Objectives

1. Develop a management plan for imaging and follow-up of infants with prenatally detected urinary tract dilation.
2. Explain why a postnatal kidney ultrasound performed before 72 hours of life may provide a falsely reassuring result and fail to detect pathological conditions.
3. Identify the history, laboratory tests, and imaging studies required to monitor children with solitary, horseshoe, or pelvic kidneys.
4. Summarize sports participation recommendations for children with a single kidney and compare them to guidance for children with other single organs.
5. Recognize clinical signs suggestive of primary immunodeficiency in children.
6. Develop a basic immunology workup for a child suspected of having immunodeficiency.
7. Explain the significance of abnormal newborn screening results for Severe Combined Immunodeficiency (SCID) in North Carolina.
8. Identify clinical scenarios where estrogen-containing hormonal medications are contraindicated.
9. Explain risk stratification categories for hormonal medication use.
10. Select safe and effective alternatives to estrogen-containing hormonal medications.
11. Describe indications for initiating airway clearance device technology and the role of pulmonary function testing.
12. Compare the features and functions of commonly used airway clearance devices.
13. Summarize the natural history of tic disorders in children.
14. Identify the differential diagnosis of tics in pediatric patients.
15. Describe an effective diagnostic approach for tic disorders.
16. Outline evidence-based treatment strategies and key considerations for managing tic disorders.
17. Recognize common complications associated with tracheostomy and gastrostomy tube care, including early warning signs and referral criteria.
18. Differentiate between urgent and non-urgent scenarios requiring specialist input or emergency evaluation.
19. Address frequently asked questions from families regarding illness management in home and outpatient settings.
20. Discuss common pitfalls in managing supportive technology and strategies to avoid them.
21. Summarize current literature on supportive devices and emerging innovations.
22. Identify common disorders that can mimic seizures or other neurologic conditions in children.
23. Distinguish features suggestive of benign conditions from red flags indicating true neurologic disease.
24. Describe the spectrum of orthostatic intolerance (OI) disorders, including postural orthostatic tachycardia syndrome (POTS).
25. Review treatment options to improve symptoms of OI.
26. Provide a framework for when to refer patients to Cardiology or other specialists.
27. Define vaccine hesitancy and explain its complexities.
28. Summarize recent policy changes related to vaccines.
29. Discuss current epidemiology for select vaccine-preventable diseases.
30. Explain the evidence informing vaccine mandates.
31. Identify evidence-based community interventions to promote vaccine uptake.
32. Describe effective communication strategies for discussing vaccines with patients.
33. Identify risk factors for cerebral palsy.
34. Differentiate conditions that meet criteria for cerebral palsy from those that do not.
35. Determine appropriate timing for referral to therapies or further evaluation.
36. Explain the etiologies and classification of common childhood anemias.
37. Describe the diagnosis and management of iron deficiency anemia.
38. Summarize the etiologies and management strategies for thrombocytopenia and neutropenia.
39. Define essential terms related to gender identity development and distinguish between gender identity, sexual orientation, and gender expression.
40. Discuss normal variations in gender identity development among children and adolescents.
41. Explain the increased risk of abuse among gender-diverse youth and its contributing factors.
42. Identify strategies for creating a psychologically safe clinical environment, including affirming language and inclusive practices.
43. Outline best practices for screening, documentation, and intervention to support gender-diverse patients while minimizing stress.

Session Credits

Credit will be awarded based on participant selection at time of registration. Before selecting credits, participants are encouraged to review our Credit Glossary (opens in new tab) for general information. Please note that not all credit types are available for every program.

Presenter(s)

• Lara Arrendondo, NP
• Amanda Blair, MD
• Adam Blatt, MD, PhD
• Jordan Fett, MD
• Meggan Goodpasture, MD
• Robert Goodrich, MD
• Greg Gorman, MD
• Shaketha Gray, MD
• Giya Harry, MD, MPH, MSc
• Matthew Hazle, MD
• Julie Kerth, MSN, PNP-AC
• Matthew Martin, MD
• Jaclyn Martindale, DO
• Thomas McLean, MD
• Megyn Sebesta, DO
• Benjamin Stewart-Bates, DO

Session Details